Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-017409

Options or other derivatives

  • Director acquired 40,006 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Castelein Caley Director 2025-06-12 Grant or award · Stock Option (right to buy) +40,006 40,006 D
Loading xslF345X05/form4-06162025_080636.xml…